Date: Thursday, August 1, 2019
Time: 2pm ET | 1pm CT | Noon CT | 11am Pacific

Speakers: David Y. Kan and Harry Nelson

As opioid addiction continues to claim lives and litigation continues to expand, attorneys who may have potential clients – as plaintiffs or defendants – will benefit from this 95-minute session with Dr. David Kan, who has been retained by plaintiffs in the opioid MDL in Ohio, and noted attorney, expert and author Harry Nelson. This live webinar is designed to give a balanced overview of the history, use and health effects of opioids. In other words: How opioids work on the human brain, why they are they so deadly, and how we got here.

The webinar will cover:

  • A history of opioid use in the United States.
  • The socio-economic aspects of opioid use and abuse.
  • The impact of opioids on the brain.
  • The multi-phase development of the epidemic.
  • What makes opioids so addictive.
  • Overdoses: Prescribed and non-prescribed medicines.
  • Treatment and rehabilitation.
  • The future of opioids in the United States. 


Author and attorney Harry Nelson is founder of Nelson Hardiman LLP, the largest healthcare and life sciences specialty law firm in Los Angeles. Harry is the author of The United States of Opioids: A Prescription for Liberating a Nation in Pain, published by Forbes in March 2019, which received critical praise for changing the crisis-related conversation from spectacle to solutions. The book grew out of Harry’s work in opioid overdose and other crisis response in behavioral health. In 2017, Harry co-authored From ObamaCare to TrumpCare: Why You Should Care, an exploration of U.S. health policy past, present, and future aimed at moving beyond rhetoric and hand-wringing to bipartisan dialogue.

Like his books, Harry’s work as an advisor focuses on practical solutions to problems at the intersection of healthcare transformation and regulatory and reimbursement compliance and strategy. While his experience has extended into virtually every facet of healthcare facilities and life science organizations, his work in recent years has emphasized digital and behavioral health, retail medical models, and emerging therapeutics including cannabis and biologic products.

Dr. David Y. Kan received his BA and MD degree from Northwestern University and he completed his residency in Psychiatry and postdoctoral training in Forensic Psychiatry at University of California, San Francisco, Medical Center. He is certified by the American Board of Psychiatry and Neurology in Psychiatry with Added Qualifications in Forensic Psychiatry.

His areas of special clinical and forensic psychiatric interest include substance use disorders, violence and suicide risk assessment, medical malpractice, and impaired professionals. He currently maintains a clinical faculty appointment at the University of California, San Francisco and works full-time in Substance Abuse Treatment in private practice and as Chief Medical Officer of Bright Heart Health, a national telemedicine addiction treatment program.